Change in Cognition Following Ischaemic Stroke
ABSTRACT Objective Cognitive decline can occur following ischaemic stroke. How cognition changes over time and associations with cognitive change are poorly understood. This study aimed to explore these issues over 2 years following ischaemic stroke.
Wenci Yan +8 more
wiley +1 more source
RETRACTION: Antibody Immune Responses and Causal Relationships in Four Immune Skin Diseases: Evidence From Mendelian Randomization and Bayesian Weighting (Antibody Responses in Skin Diseases: MR & Bayesian). [PDF]
europepmc +1 more source
Mendelian randomization reveals contrasting effects of immune signaling molecules on bone and articular cartilage malignancies. [PDF]
Huang H, Lin Y, Xiang M, Fu J.
europepmc +1 more source
ABSTRACT Objective The optimal treatment for neurosarcoidosis myelitis is uncertain. We characterize incident neurosarcoidosis myelitis and assess treatment response by MRI and clinical scales. Methods Incident probable or definite neurosarcoidosis myelitis in adults was retrospectively identified from 13 academic medical centers.
Giovanna S. Manzano +39 more
wiley +1 more source
RETRACTION: Causal Relationship between Inflammatory Skin Diseases and Breast Cancer: A Bidirectional Mendelian Randomization Study. [PDF]
europepmc +1 more source
Specific plasma lipid species in children are causally associated with kawasaki disease: a mendelian randomization analysis. [PDF]
Zhen C, Zhang S, Guo F.
europepmc +1 more source
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
RETRACTION: Serum Lipids May Causally Affect the Occurrence of Alopecia Areata: A Mendelian Randomization Study. [PDF]
europepmc +1 more source
Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals. [PDF]
Nordestgaard LT +7 more
europepmc +1 more source

